Bone abnormalities occurring in the follow-up of the patients with neurofibromatosis type 1.

作者: E F Georgescu , Daniela Dumitrescu , Ana Claudia Georgescu , Ligia Stănescu , Claudia Foarfă

DOI:

关键词:

摘要: Neurofibromatosis type 1 (NF1), also called von Recklinghausen disease or peripheral neurofibromatosis, is a common autosomal dominant disorder characterized by multiple neurofibromas, "cafe au lait" spots and Lisch nodules of the iris with variable clinical expression. Osseous anomalies appeared in patients NF1 including dysplasia, scoliosis pseudoarthrosis. We propose research osseous involvement at 11 patients, seven female four male ages from 9 to 60 which cutaneous aspect has complete form, hyperpigmented neurofibromas only more than six spots. All suffered radiological exams, CT- MRI-scan. The results were different case extreme severe deformations, especially children, unapparent involvement, incidental found occasion our investigation. CONCLUSIONS. abnormalities specific disease, like scoliosis, pseudoarthrosis, often gentle but sometimes extremely severe. most are presented cases when these development early childhood. Other times asymptomatic, their finding been incidental. want have separate mention for maxillary mandible according information not rare form.

参考文章(21)
Maryellen M. Daston, Heidi Scrable, Michael Nordlund, Anne K. Sturbaum, Lisa M. Nissen, Nancy Ratner, The protein product of the neurofibromatosis type 1 gene is expressed at highest abundance in neurons, Schwann cells, and oligodendrocytes Neuron. ,vol. 8, pp. 415- 428 ,(1992) , 10.1016/0896-6273(92)90270-N
Robert Listernick, Joel Charrow, Mark Greenwald, Marilyn Mets, Natural history of optic pathway tumors in children with neurofibromatosis type 1: a longitudinal study The Journal of Pediatrics. ,vol. 125, pp. 63- 66 ,(1994) , 10.1016/S0022-3476(94)70122-9
J.M. Friedman, Epidemiology of neurofibromatosis type 1 American Journal of Medical Genetics. ,vol. 89, pp. 1- 6 ,(1999) , 10.1002/(SICI)1096-8628(19990326)89:1<1::AID-AJMG3>3.0.CO;2-8
J.M. Friedman, Neurofibromatosis 1: clinical manifestations and diagnostic criteria. Journal of Child Neurology. ,vol. 17, pp. 548- 554 ,(2002) , 10.1177/088307380201700802
Kimberly DeBella, Jacek Szudek, Jan Marshall Friedman, Use of the national institutes of health criteria for diagnosis of neurofibromatosis 1 in children. Pediatrics. ,vol. 105, pp. 608- 614 ,(2000) , 10.1542/PEDS.105.3.608
R. Listernick, R. E. Ferner, L. Piersall, S. Sharif, D. H. Gutmann, J. Charrow, Late-onset optic pathway tumors in children with neurofibromatosis 1. Neurology. ,vol. 63, pp. 1944- 1946 ,(2004) , 10.1212/01.WNL.0000144341.16830.01
J. E. DeClue, B. D. Cohen, D. R. Lowy, Identification and characterization of the neurofibromatosis type 1 protein product. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 88, pp. 9914- 9918 ,(1991) , 10.1073/PNAS.88.22.9914
David H. Gutmann, The Diagnostic Evaluation and Multidisciplinary Management of Neurofibromatosis 1 and Neurofibromatosis 2 JAMA: The Journal of the American Medical Association. ,vol. 278, pp. 51- 57 ,(1997) , 10.1001/JAMA.1997.03550010065042
Jean-Christophe Drappier, Kiarash Khosrotehrani, Jacques Zeller, Jean Revuz, Pierre Wolkenstein, Medical management of neurofibromatosis 1: a cross-sectional study of 383 patients. Journal of The American Academy of Dermatology. ,vol. 49, pp. 440- 444 ,(2003) , 10.1067/S0190-9622(03)01481-6
Douglas A. Marchuk, Ann M. Saulino, Roxanne Tavakkol, Manju Swaroop, Margaret R. Wallace, Lone B. Andersen, Anna L. Mitchell, David H. Gutmann, Mark Boguski, Francis S. Collins, cDNA cloning of the type 1 neurofibromatosis gene: Complete sequence of the NF1 gene product Genomics. ,vol. 11, pp. 931- 940 ,(1991) , 10.1016/0888-7543(91)90017-9